Zajicek, J;
Ball, S;
Wright, D;
Vickery, J;
Nunn, A;
Miller, D;
Gomez Cano, M;
... CUPID investigator group; + view all
(2013)
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Lancet Neurology
, 12
(9)
857 - 865.
10.1016/S1474-4422(13)70159-5.
Preview |
PDF
1-s2.0-S1474442213701595-main.pdf Download (418kB) |
Abstract
Laboratory evidence has shown that cannabinoids might have a neuroprotective action. We investigated whether oral dronabinol (Δ(9)-tetrahydrocannabinol) might slow the course of progressive multiple sclerosis.
Archive Staff Only
View Item |